Form 4: NeueHealth Director's Post-Merger Ownership Update

Sentiment:

Insider Ownership Change / Merger Update 6 October 2025 5:53 PM

Paul Edward Walker, a director and 10% owner of NeueHealth, Inc., reported significant changes in his beneficial ownership following the company's merger on October 2, 2025.

Worse than expectedThe company's shares were cancelled as part of a merger, meaning NeueHealth, Inc. is no longer a publicly traded entity.Public shareholders who were not part of the rollover agreements would have had their shares converted into cash or other consideration, losing their direct equity stake in the company.

Summary

Paul Edward Walker, a director and 10% owner of NeueHealth, Inc. (NEUE), filed a Form 4 detailing changes in his beneficial ownership.
The changes occurred on October 2, 2025, following the merger of Merger Sub into NeueHealth, Inc., with NeueHealth surviving as a wholly-owned subsidiary of NH Holdings 2025, Inc. ('Parent').
Pursuant to rollover agreements, shares of NeueHealth's Common Stock, Series A Convertible Perpetual Preferred Stock, and Series B Convertible Perpetual Preferred Stock beneficially owned by the reporting persons were contributed to NH Holdings 2025 SPV, L.P. ('Ultimate Parent') in exchange for limited partnership interests.
Subsequently, all such shares of NeueHealth's Common Stock, Series A Preferred Stock, and Series B Preferred Stock were cancelled and ceased to exist.
Transactions included the exercise of warrants (right to buy) for Common Stock at an exercise price of $0.01 per share.
Dispositions of Common Stock occurred at a fair market value of $6.75 per share, primarily through cashless net exercises of warrants and for tax liability payments.
The reporting person disclaims beneficial ownership of securities held by New Enterprise Associates (NEA) entities where he has no pecuniary interest, despite being a manager of their general partners.

Sentiment

Score: 3

Explanation: The filing reports a significant corporate event (merger) that results in the cancellation of public shares, effectively taking the company private. While potentially strategic for the company's long-term private growth, it eliminates public investment opportunities and liquidity for existing public shareholders.

Positives

The reporting person exercised warrants at a nominal price of $0.01 per share, indicating a significant potential gain on those shares.
The merger event, while changing the company's public status, represents a strategic corporate action for NeueHealth and its new parent entity.

Negatives

NeueHealth, Inc. ceased to be a publicly traded entity, as its shares were cancelled following the merger into a wholly-owned subsidiary.
Public shareholders who were not part of the rollover agreements would no longer hold shares in NeueHealth, Inc.

Risks

The company is no longer publicly traded, eliminating liquidity and investment opportunities for public shareholders.
The value of the limited partnership interests received by reporting persons in the Ultimate Parent is subject to the performance of the private entity.

Future Outlook

The future outlook for NeueHealth, Inc. as a publicly traded entity is non-existent, as it has become a wholly-owned subsidiary of a private parent company. Its operations and strategic direction will now be determined within the private structure of NH Holdings 2025, Inc. and NH Holdings 2025 SPV, L.P.

Industry Context

The merger of NeueHealth, Inc. into a private entity reflects a broader trend of public companies being acquired and taken private, often by private equity firms like New Enterprise Associates (NEA). Such transactions typically aim to restructure operations, reduce public reporting burdens, and pursue long-term growth strategies away from public market pressures. This move positions NeueHealth within a private investment portfolio, aligning with the strategic objectives of its new parent company.

Comparison to Industry Standards

The acquisition of a public company by a private entity, leading to its delisting, is a common strategy in the private equity industry, often seen when firms aim to implement significant operational changes or capitalize on perceived undervaluation without public market scrutiny.
The use of rollover agreements, where existing equity holders exchange their shares for interests in the acquiring private entity, is a standard mechanism in such transactions, particularly for significant shareholders or founders who wish to maintain an equity stake in the privatized company.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Corporate Structure	NeueHealth, Inc. transitioned from a publicly traded company to a wholly-owned subsidiary of NH Holdings 2025, Inc. following a merger.	10/02/2025	This fundamentally alters the corporate governance framework, moving from public company regulations and oversight to a private governance model, likely reducing public disclosure requirements and increasing control by the parent entity.

Related Party Transactions

The reporting person, Paul Edward Walker, is a manager of the general partners for various New Enterprise Associates (NEA) entities (NEA 16, NEA 17, NEA 18 VGE) which were direct beneficial owners of the securities.
The merger involved rollover agreements between certain reporting persons (including entities related to NEA) and NH Holdings 2025 SPV, L.P. ('Ultimate Parent'), where shares were contributed in exchange for limited partnership interests.

Stakeholder Impact

Shareholders: Public shareholders of NeueHealth, Inc. no longer hold shares in the company, as they were cancelled as part of the merger. Those who participated in rollover agreements received limited partnership interests in the Ultimate Parent.
Employees: The filing does not directly address employee impact, but a change in ownership structure can lead to changes in compensation, benefits, or organizational structure.
Customers/Suppliers: The filing does not directly address impact on customers or suppliers, but a change in ownership could lead to strategic shifts that affect these relationships.

Next Steps

NeueHealth, Inc. will operate as a wholly-owned subsidiary of NH Holdings 2025, Inc. within a private structure.
The reporting person's beneficial ownership is now indirect through limited partnership interests in NH Holdings 2025 SPV, L.P.

Key Dates

Date	Description
08/04/2023	Date of the original Credit Agreement.
08/29/2023	Warrants became exercisable as to 828,395 shares.
09/18/2023	Warrants became exercisable as to 552,263 shares.
10/02/2023	Date of Incremental Amendment No. 1 to the Credit Agreement.
11/01/2023	Warrants became exercisable as to 100,606 shares.
12/20/2023	Warrants became exercisable as to 175,525 shares.
12/23/2024	Date of the Agreement and Plan of Merger.
04/08/2024	Date of Incremental Amendment No. 2 to the Credit Agreement.
04/30/2024	Warrants became exercisable as to 123,729 shares and 371,187 shares.
06/21/2024	Date of Amendment No. 3 to the Credit Agreement; warrants became exercisable as to 1,733 shares and 28,399 shares.
10/02/2024	Warrants became exercisable as to 61,865 shares and 185,595 shares.
10/29/2024	Date of Amendment No. 4 to the Credit Agreement.
09/26/2025	Warrants became exercisable as to 1,868 shares and 22,355 shares.
09/30/2025	Date of the Warrantholders Agreement and Amendment No. 5 to the Credit Agreement.
10/01/2025	Closing market price of Issuer's common stock was $6.75 per share.
10/02/2025	Date of earliest transaction; Merger effective date; Warrants became fully exercisable; Expiration date for certain warrants.
10/06/2025	Signature date of the reporting person's attorney-in-fact.
10/02/2030	Expiration date for certain warrants.

Recommendation

sell

The company has undergone a merger, resulting in its shares being cancelled and ceasing to exist as publicly traded securities. Public shareholders would have received cash or other consideration, making the stock no longer tradable. Any remaining shares would be illiquid or converted into interests in a private entity, thus a 'sell' recommendation reflects the cessation of public trading.

Keywords

NeueHealth, NEUE, Form 4, insider ownership, merger, beneficial ownership, private equity, New Enterprise Associates, Paul Edward Walker, corporate action, stock cancellation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.